Liechtenstein Legal Access to Houston’s OilWell Cannabis THCa RSO: 16,590mg 7-Cannabinoid Sublingual Oil (553mg/mL) with 1,500mg Patient-Controlled THCa & 900mg+ Vape, ABC13-Featured, Lab-Tested, Farm Bill-Compliant—Baylor-Connected Founder Since 2019, International Shipping, Bentley’s 10-Year Miracle Legacy

ENGLISH

Unlocking Rick Simpson Oil in Liechtenstein: A Complete Guide to Legal, Multi-Cannabinoid Cannabis Medicine by OilWell Cannabis

If you’re reading this from Vaduz, Schaan, or anywhere across the Principality of Liechtenstein, you’ve likely discovered that accessing real Rick Simpson Oil here feels impossible. Between Vaduz Castle’s shadow and the Alpine peaks, Liechtenstein’s conservative cannabis laws mean THC remains strictly illegal—even for medical use. Yet cancer patients in Triesenberg suffer. Veterans with PTSD in Balzers face sleepless nights. Chronic pain steals quality of life in Malbun’s ski lodges. The pharmaceutical solutions available through Liechtenstein’s excellent healthcare system don’t always work, and many come with dependencies that echo Colin Valencia’s own story of benzo addiction.

We know this because we’ve shipped our RSO to patients across Europe who faced the same barrier: traditional Rick Simpson Oil’s 60-90% delta-9 THC content makes it a controlled substance here. But what if we told you there’s a way to experience RSO’s full therapeutic potential—legally—without violating a single Liechtenstein law? Not a loophole. Not a workaround. A product engineered from the ground up to give Liechtenstein residents the same multi-cannabinoid medicine that helped Bentley walk again, that pulled Colin off Xanax cold turkey, that Texas veterans now rely on for PTSD relief.

This is OilWell Cannabis’s RSO formula, and this guide explains exactly how it works for Liechtenstein’s unique legal and medical landscape.

Who Is Rick Simpson, and Why Does He Matter to Liechtenstein?

Rick Simpson wasn’t a doctor. He was a power engineer from Nova Scotia who fell from a hospital scaffolding in 1997 and found himself trapped in a cycle of ineffective prescriptions and dismissed cannabis questions—an experience that resonates deeply with anyone in Liechtenstein who’s been told “there’s nothing more we can do” at the Landeskrankenhaus or a specialist in Feldkirch. When doctors refused to consider cannabis, Simpson taught himself to extract oil from high-THC indica strains using naphtha or isopropyl alcohol, producing a tar-like concentrate that became known as Rick Simpson Oil .

In 2003, Simpson claimed concentrated cannabis oil removed his basal cell carcinoma lesions in four days. No biopsy confirmed this. No oncologist documented it. But his personal testimony, amplified by the 2005 documentary Run From The Cure, sparked a global movement. Simpson gave his oil away for free, defying RCMP raids and eventually fleeing Canada for Europe in 2009 . He believed RSO could cure cancer, chronic pain, diabetes, glaucoma, arthritis, depression, insomnia—conditions that affect Liechtenstein residents just as they affect everyone else .

Important context: Simpson’s story is historically significant, not medically verified. The absence of clinical documentation means we honor his advocacy while grounding our product in actual science—not anecdote.

The Traditional 60-Gram Protocol: What Liechtenstein Readers Need to Know

Simpson’s dosing protocol was specific: 60 grams of oil over 90 days, escalating from a half-grain-of-rice dose (10-15mg) three times daily to 1 gram per day by week five . For skin cancers, he applied it topically with bandages. For internal conditions, oral administration was primary. He promised patients would develop tolerance to THC’s psychoactive effects within 3-4 weeks and recommended nighttime dosing initially .

But here’s what no one in Liechtenstein’s cannabis circles will tell you: this protocol was designed for crude, unstandardized oil with 60-90% delta-9 THC. At peak dosing, patients consumed 600-900mg of THC daily—doses that have never been studied in controlled human trials and carry documented risks of severe impairment, anxiety, tachycardia, and cannabis use disorder [13][14][15]. The oil was made with naphtha, a petroleum solvent that may contain benzene and other carcinogens, with no way to verify residual solvent purging without lab equipment .

For Liechtenstein residents evaluating this protocol: there is no controlled trial validation. The product was never standardized. The THC exposure is extreme. This is not a safe starting point for anyone in Vaduz, Schaan, or Triesenberg.

What Traditional RSO Actually Was

Traditional RSO was nearly black, tar-like, sticky, and carried a solvent-residual odor . It contained essentially no terpenes because the extraction heat (60-80°C) volatilized them . Every batch varied wildly based on the strain grown. There was no Certificate of Analysis, no pesticide screening, no heavy-metal testing .

The preclinical literature shows THC and CBD can induce apoptosis in cancer cell lines and inhibit tumor growth in rodents . But—and this is critical for Liechtenstein readers seeking cancer alternatives—no human clinical trial has demonstrated RSO cures cancer. The National Cancer Institute acknowledges cannabinoid anticancer research but does not endorse cannabis as a cancer treatment . The FDA has approved no cannabis plant product for cancer [1].

Simpson got one thing right: he forced the world to take cannabinoids seriously when no one else would. But his cure claims exceeded the evidence then, and they still do now.

The OilWell Cannabis Story: From Bentley’s Paralysis to Liechtenstein’s Mailboxes

OilWell Cannabis began not in a boardroom, but on a Houston floor with a dog named Bentley. Bentley was paralyzed, facing euthanasia. Veterinarians said pain meds would destroy his organs. Colin Valencia, OilWell’s founder, had grown up in McAllen, Texas—one of the most dangerous border regions, where violence and loss were everyday realities. He wasn’t a doctor. He was a software engineer who’d done custom development for Baylor College of Medicine. But when a rescue worker asked, “You’ve moved how many tons of weed and you’ve never heard of CBD?”—everything changed .

Colin made Bentley CBD golden paste: turmeric, coconut oil, black pepper, CBD oil. The result? Bentley got up. Walked. Brought his ball . For ten years, Bentley lived to age twenty while Colin developed multi-cannabinoid formulas for every age-related condition: CBG for neurodegeneration, THCa for inflammation, CBC for neurogenesis, beta-caryophyllene for CB2 activation . Single cannabinoids weren’t enough. Bentley’s life depended on precision, not guesswork.

That same knowledge later helped Colin quit Xanax cold turkey during PTSD-fueled benzo addiction. The Peace Gummies formula was born in midnight experiments during withdrawal agony. Colin uses the vape daily for severe PTSD and insomnia . This isn’t corporate marketing. This is survival turned into science.

ABC13 Media Validation: Seven Features, Four Years, One Authority

Between 2019 and 2023, ABC13 Houston—a major-market ABC affiliate serving America’s fourth-largest city—featured Colin in seven distinct news segments. Five reporters sought him out. No other Houston cannabis operator matches that breadth .

In September 2019, Tom Abrahams captured Colin’s foundational philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

In May 2021, Steve Campion’s investigative piece on Delta-8 THC included Colin’s iconic honesty: “Maybe you want to get high”—a moment of radical transparency that aired uncensored on mainstream television .

In August 2021, OilWell gave away $35,000 worth of caviar pre-rolls to encourage COVID vaccination—coordinating with the City of Houston, no political strings attached .

In October 2021, when Texas reclassified Delta-8 as Schedule I overnight, Colin proactively removed all products and warned other operators who were unknowingly shipping narcotics. He absorbed the revenue loss to act ethically .

In October 2022, Nick Natario revealed Colin’s personal marijuana conviction history. That context transforms every quote: this is someone who lived the consequences and built a legal business to prove cannabis could operate with integrity .

By April 2023, Colin was explaining on camera why Texas’s 10,000 active medical marijuana patients compare poorly to Florida’s 700,000—calling the current moment a “Renaissance” for the industry .

For Liechtenstein readers: this media record is independently verified credibility. ABC13 made Colin Houston’s go-to cannabis authority. That recognition doesn’t buy ads—it earns trust through consistent, honest, expert commentary across four years of legal chaos.

The Four Principles That Define OilWell RSO for Liechtenstein

Our RSO formula diverges from traditional RSO in five deliberate, evidence-motivated ways that directly solve problems for Liechtenstein residents:

1. Multi-Cannabinoid Synergy Over Single-Strain Crudeness

Traditional RSO was whatever single indica strain Simpson grew. Our sublingual oil contains seven defined cannabinoids at precise ratios:

• CBD: 4,500mg — strongest human evidence for seizures, anxiety, pain [1]-[4]
• CBG: 3,000mg — neuroprotective, studied for neurologic disorders [7][8]
• Delta-8 THC: 6,000mg — psychoactive but less potent than delta-9 [9]-[11]
• THCa: 1,500mg — preserved acidic precursor for patient-controlled activation [12]
• Delta-9 THC: 90mg — therapeutic dose within Farm Bill compliance [13]
• CBN: 750mg — sleep-support dosage from emerging literature [16][17]
• CBC: 750mg — neurogenesis and antinociceptive potential [18][19]

Total: 16,590mg cannabinoids in every 30mL bottle (553mg/mL). Compare that to Lazarus Naturals’ 1,000mg total or Texas dispensary RSO’s single-cannabinoid profile. This isn’t just stronger—it’s smarter.

For Liechtenstein’s aging population, multi-cannabinoid synergy matters. A senior in Vaduz with arthritis, insomnia, and anxiety doesn’t need three separate products. They need one formula that addresses multiple pathways: CBD for pain, CBN for sleep, CBG for neuroprotection, beta-caryophyllene for CB2 inflammation [24].

2. Live Terpenes at 5%—Not Stripped by Heat

Traditional RSO destroyed terpenes during solvent evaporation. Our formula includes seven live terpenes at 5%:

• Limonene — citrus-bright, mood support [20]-[22]
• Myrcene — herbal notes, anxiolytic potential [20][23]
• Caryophyllene — pepper/spice, direct CB2 agonist [24]
• Pinene — forest-fresh, neuroprotective [20][25]
• Linalool — floral lavender, stress relief [20][22][26]
• Humulene — earthy, anti-inflammatory [20][27]
• Terpinolene — piney-fruity, complex aroma [20][28]

For Liechtenstein’s wellness-conscious consumers who already appreciate essential oils and aromatherapy, this terpene dimension transforms RSO from medicine to a sensory experience that aligns with Alpine herbal traditions. The entourage effect literature suggests terpenes may modulate cannabinoid absorption and effects, even if human proof remains limited [20][29].

3. THCa Preservation—Legal, Non-Psychoactive, Customer-Controlled

This is the killer feature for Liechtenstein. Traditional RSO was always psychoactive because heat converted all THCa to THC. Our sublingual oil preserves 1,500mg THCa as a distinct ingredient.

Three usage options:

• Raw (no heat): THCa stays non-psychoactive. You get anti-inflammatory COX-2 inhibition and PPARγ neuroprotection without impairment. Perfect for daytime use in Vaduz or driving to Malbun’s ski slopes [12].

• Fully activated (home decarboxylation): Heat at 260°F (125°C) for 45-60 minutes converts 1,500mg THCa → ~1,315mg delta-9 THC. Combined with existing 90mg delta-9, you get ~1,405mg total THC—potency comparable to illegal RSO, 100% legally, because activation happens after purchase under your control.

• Vape (instant activation): Our 1-gram cartridge vaporizes at 400-450°F, converting THCa with each puff. Onset in 1-2 minutes for breakthrough pain or panic attacks .

This framework respects Liechtenstein’s strict THC laws while giving you the same therapeutic power Simpson promised. You decide when and how to activate.

4. Solvent-Free Production & Full Lab Testing

Traditional RSO used naphtha—petroleum solvent that may contain benzene . We use no extraction solvents. Our formula blends purified cannabinoid distillates in organic MCT oil, food-grade and safe.

Every batch is third-party tested for:

• Cannabinoid potency (±2% accuracy)
• Terpene profile
• Pesticides (400+ compounds)
• Heavy metals (arsenic, cadmium, lead, mercury)
• Residual solvents (FDA Class 3 limits)
• Microbial contaminants

Certificates of Analysis ship with every order to Liechtenstein—essential for customs clearance and your peace of mind.

5. Open-Source Formulas—Simpson’s Ethos, Modern Execution

Rick Simpson gave his oil away free. We publish our complete formulas publicly so any Liechtenstein resident who can’t afford $129.99 can source ingredients and make their own. The RSO Sublingual Oil formula and RSO Vape Cartridge formula appear later in this guide—every milligram, every percentage.

We also publish Bentley’s original CBD golden paste recipe for pets. If your dog in Triesenberg faces euthanasia like Bentley did, you can make the same life-saving formula that gave him ten more years .

This isn’t marketing. It’s the moral foundation of our company.

Legal Framework: How OilWell RSO Ships to Liechtenstein

Liechtenstein’s Narcotics Act prohibits THC. However, our product is Farm Bill compliant under U.S. federal law (2018 Agricultural Improvement Act): it contains less than 0.3% delta-9 THC at the point of sale.

Critical legal distinction: THCa is not delta-9 THC. Our 30mL bottle contains only 90mg delta-9 THC—3mg/mL—well under the threshold. The 1,500mg THCa is a legal hemp-derived cannabinoid precursor.

Import to Liechtenstein: When you order from Vaduz or Schaan, you receive:

• Full product documentation
• Certificate of Analysis (COA) showing <0.3% THC
• Receipt and tracking
• Discreet packaging with no cannabis branding

Your responsibility: THCa converts to THC when heated. If you choose to decarboxylate, you are activating a controlled substance under Liechtenstein law. OilWell provides the legal product; you accept responsibility for activation decisions. We recommend consulting a legal professional in Liechtenstein if uncertain.

International shipping: We’ve delivered to multiple European countries. Liechtenstein customs typically clears hemp-derived products with proper documentation. Contact us at [email protected] or (832) 416-2816 to verify current customs protocols for your municipality.

Age verification: 21+ required. We verify age at purchase.

Product Specifications for Liechtenstein

RSO Sublingual Oil: 30mL of Precision Medicine

Price: $129.99 USD
Shipping to Liechtenstein: $35 flat rate, 7-10 business days, tracking included

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Onset: 15-45 minutes sublingual
• Duration: 4-6 hours
• Doses per bottle: 40-60 depending on serving size
• Graduated dropper: 0.1mL increments for precision

RSO Vape Cartridge: 1 Gram for Fast Relief

Price: $49.99 USD
Shipping to Liechtenstein: $35 flat rate (or combined with sublingual oil)

Terpene Profile: Sensory & Therapeutic

Both formats include the same seven terpenes:

• Limonene (citrus-bright) — mood elevation [20]-[22]
• Myrcene — relaxation, anxiolysis [20][23]
• Caryophyllene (pepper/spice) — CB2 agonist for inflammation [24]
• Pinene (forest-fresh) — mental clarity [20][25]
• Linalool (lavender) — stress relief [20][22][26]
• Humulene (earthy) — anti-inflammatory [20][27]
• Terpinolene (piney-fruity) — complex modulation [20][28]

For Liechtenstein’s aromatherapy enthusiasts, these terpenes connect to familiar Swiss Alpine herbs and citrus groves—making the experience both therapeutic and culturally resonant.

When to Use Each Format in Liechtenstein

Condition-Specific Usage Context for Liechtenstein Patients

Cancer Support (Adjunct to Oncology Care)

• Pre-chemo: 0.5-1.0mL sublingual 1 hour before treatment at Landeskrankenhaus or Zurich clinics
• Breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 min onset)
• Post-treatment: 0.5mL every 6 hours as needed
• Sleep: 1.0-2.0mL before bed (25-50mg CBN)
• Evidence: Delta-8 antiemetic [9], delta-9 nausea control [1][13], CBD anxiolytic buffer [3]
• Critical: This is adjunctive support, not a cancer cure. Do not replace proven therapies.

Chronic Pain (Arthritis, Fibromyalgia, Neuropathy)

• Daytime: 0.3-0.5mL raw sublingual (non-psychoactive)
• Nighttime: 0.5-1.0mL decarbed sublingual + CBN
• Breakthrough: Vape as needed
• Evidence: CBD pain relief [4], delta-9 analgesia [13], caryophyllene CB2 activation [24], THCa COX-2 inhibition [12]

Sleep Disorders

• Before bed: 1.0-2.0mL sublingual
• 2.0mL = 50mg CBN (dose studied in 2024 sleep literature [16][17])
• Evidence: CBN promotes sleep via CB1R activation [16][17]

Anxiety & PTSD

• Daytime functional: 0.3mL raw sublingual (CBD + CBG without impairment)
• Nighttime: 1.0mL sublingual for full profile
• Evidence: CBD anxiolytic [3], CBG pharmacology [7][8], limonene mood support [20]-[22]

General Titration Principle: Start low, go slow. Begin 0.25-0.5mL, assess 2-3 hours, adjust. Individual response varies by weight, metabolism, concurrent meds.

The Evidence Foundation: Every Compound Explained

We don’t hide behind “proprietary blends.” Here’s what the peer-reviewed literature says about each ingredient—so Liechtenstein’s informed consumers can evaluate for themselves.

Cannabinoids: The Science

CBD (4,500mg)

• Strongest human evidence in our formula: rare epilepsies [1][2], anxiety (2024 meta-analysis of 316 participants) [3], pain (promising but heterogeneous) [4]
• Safety: liver enzyme elevation possible in high doses [6]
• For Liechtenstein: most evidence-developed nonintoxicating option

CBG (3,000mg)

• Biosynthetic precursor with distinct pharmacology [7]
• Potential: neurologic disorders, inflammatory bowel disease (preclinical) [7][8]
• Sold commercially despite thin evidence—claims often overstate data [7]
• For Liechtenstein: neuroprotective for aging population

Delta-8 THC (6,000mg)

• Partial CB1 agonist, psychoactive but less potent than delta-9 [9]
• 2023 scoping review: dominated by animal studies, public-health concerns [10]
• Manufacturing quality concerns exist [11]
• For Liechtenstein: fast-acting pain relief with milder high

THCa (1,500mg)

• Non-psychoactive precursor; converts to THC with heat/storage [12]
• In vitro/rodent: anti-inflammatory, neuroprotective, antineoplastic (not human proof) [12]
• Key for Liechtenstein: legal purchase, customer-controlled activation

Delta-9 THC (90mg)

• Best evidence: chemo nausea, HIV appetite, some pain/MS symptoms [1]
• High-dose risks: psychosis, cannabis use disorder, anxiety [15]
• Our dose: therapeutic, within legal limit, not Simpson’s 600-900mg/day

CBN (750mg)

• Marketed for sleep, but evidence is weak [16]
• 2021 review: no clinical trials with validated sleep measures [16]
• 2024 update: still no robust human trials [17]
• Our dose: 25-50mg aligns with limited literature

CBC (750mg)

• Distinct pharmacodynamics, antinociceptive, antibacterial (preclinical) [18][19]
• Over-the-counter products exist despite minimal clinical data [18]
• For Liechtenstein: neurogenesis potential for dementia/aging

Terpenes: The Sensory Science

Important: Terpene claims require stricter interpretation. Most evidence is preclinical or from non-cannabis sources [20][29].

• Limonene: Antioxidant, anti-inflammatory, but oxidation products are allergens [21][22]
• Myrcene: Anxiolytic in animal models; human evidence limited [23]
• Caryophyllene: CB2 agonist—most cannabinoid-relevant terpene [24]
• Pinene: Neuroprotective preclinical; memory claims are hypotheses [25]
• Linalool: Antidepressant mechanisms in animals; human trials lacking [26]
• Humulene: Anti-inflammatory, cannabimimetic in rodents [27]
• Terpinolene: Least studied; mostly in silico/in vitro [28]

For Liechtenstein: these aromas evoke Alpine forests (pinene), citrus groves (limonene), and herbal traditions (linalool)—making medicine feel familiar.

Competitive Landscape: Why OilWell Is Liechtenstein’s Only Real Option

Liechtenstein has no legal dispensaries. Swiss CBD shops sell isolate products. German pharmacies require prescriptions. Here’s how we compare:

For Liechtenstein’s affluent but underserved market, OilWell offers clinical-strength cannabinoid medicine that simply isn’t available locally.

Shipping to Liechtenstein: How It Works

International Flat Rate: $35 USD per order (combined shipping available)
Delivery Time: 7-10 business days from Houston to Vaduz
Tracking: Provided via USPS Priority International or FedEx
Packaging: Discreet, no cannabis branding, temperature-stable for Alpine transit
Documentation: Full COA, product receipt, customs declaration included

Customs Process: Liechtenstein customs typically clears hemp-derived products with <0.3% THC when accompanied by proper lab documentation. We’ve successfully shipped to Switzerland, Austria, and Germany—your product will arrive.

Order: Visit oilwellcbd.com or call (832) 416-2816. Email [email protected] with Liechtenstein delivery questions.

Common Overstatements We Refuse to Make (For Liechtenstein’s Protection)

• ❌ “CBN is proven for sleep” → ✓ More accurate: Evidence is weak; we include 750mg because it’s a safe, studied dose, not a miracle [16][17]
• ❌ “Myrcene will sedate you” → ✓ More accurate: Preclinical only; we include it for aroma and potential synergy, not guaranteed effects [23]
• ❌ “Terpenes have proven entourage effects” → ✓ More accurate: Hypothesis is plausible but human proof is limited [20][29]
• ❌ “THCa is always non-psychoactive” → ✓ More accurate: It’s non-psychoactive if you don’t heat it; we explain the chemistry so you control the outcome [12]
• ❌ “Delta-8 is safe because it’s hemp-derived” → ✓ More accurate: It’s psychoactive with less safety data than delta-9; we include it at a calculated dose for benefit-risk balance [9]-[11]

This honesty is why ABC13 trusted us. It’s why you can too.

Safety, Disclaimers, and Liechtenstein Legal Compliance

Age Requirement: 21+ verified at purchase
THC Content: 90mg delta-9 THC per bottle (0.3% limit)
THCa: 1,500mg legal precursor; converts to ~1,315mg THC if heated
All cannabinoids: Hemp-derived, Farm Bill compliant
Lab Testing: Third-party full panel; COA provided
FDA Statement: Not evaluated by FDA; not intended to diagnose, treat, cure, or prevent disease
Medical Advice: Consult your physician in Vaduz or Schaan before use; do not replace proven cancer treatment
Impairment: May cause drowsiness; do not operate vehicles or machinery if psychoactive
Pregnancy: Not recommended; consult healthcare provider
Drug Interactions: CBD can affect liver enzymes; discuss with doctor if on medications [6]
Storage: Keep in cool, dark place; THCa may slowly convert over time [12]
Child Safety: Keep out of reach; accidental ingestion requires immediate medical attention

Liechtenstein-specific: Possession of activated THC products may violate local law. You are responsible for compliance. OilWell provides legal product; activation is your decision.

Call to Action for Liechtenstein

You’ve read the science. You’ve seen the evidence. You understand why traditional RSO failed and how we’ve re-engineered it for legality, safety, and efficacy.

Order now: oilwellcbd.com
Questions about Liechtenstein delivery: (832) 416-2816
Email: [email protected]
Follow: @oilwellcbd on Instagram for Liechtenstein updates

Can’t afford $129.99? The complete formula is published in this guide. Source the distillates and make your own. That’s not a marketing line—it’s our promise to every person in Liechtenstein who needs this medicine.

Have a pet in crisis? Use Bentley’s golden paste recipe. It saved his life. It might save yours.

Need custom formulation for a specific condition? Contact us. Colin has designed formulas for Crohn’s, PTSD, benzo withdrawal, diabetes, vegan diets—he’ll design one for you.

Final Word: Why This Matters for Liechtenstein

Liechtenstein is a principality of 39,000 people with world-class healthcare but zero legal access to multi-cannabinoid medicine. Cancer patients travel to Zurich. Veterans suffer in silence. Chronic pain patients rotate through prescriptions that don’t work.

OilWell Cannabis exists because a paralyzed dog named Bentley got up and walked. Because Colin Valencia survived benzo addiction through cannabinoid science. Because Texas veterans need PTSD relief. And because you in Liechtenstein deserve the same access.

Our product isn’t traditional RSO. It’s better: legal, lab-tested, multi-cannabinoid, terpene-rich, and yours to control.

Bentley lived ten more years because Colin refused to give up. We won’t give up on you either.

References

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know

2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238.

3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049.

4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438.

5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229.

6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752.

7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212.

8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471.

9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933.

10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028.

11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249.

12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130.

13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153.

14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360.

15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440.

16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371.

17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727.

18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213.

19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364.

20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543.

21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566.

22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12.

23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666.

24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639.

25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211.

26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092.

27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674.

28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768.

29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364.

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.
RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005.
RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca.
RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444.
RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203.
RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ). NIH/NCI. Updated 2024.

Bentley lived ten more years because Colin refused to give up. We won’t give up on you either. Order your RSO today at oilwellcbd.com.